Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

EEG timing could be key for ICU brain care

NCT ID NCT07441434

Knowledge-focused Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study from a Swiss hospital reviewed records of 800 adult ICU patients with brain problems to see how the length of EEG monitoring influenced their diagnosis and treatment. Researchers collected data on patient history, severity of illness, lab results, and outcomes. The goal is to find the best monitoring duration to improve care for critically ill patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors decide the best length of EEG monitoring for critically ill patients, potentially improving care and outcomes.
What could go wrong
This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to other hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

800 people

The number who actually took part.

Started

Jan 2014

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will include all consecutive adult patients (i.e., ≥18 years of age) who were treated at the University Hospital Basel and/or were selected for a close monitoring on a monitoring Unit for EEG or continuous EEG between 2014 and until the end of 02/2025.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (i.e., patients ≥18 years of age) * Received an EEG/continuous EEG * Treated at the University Hospital of Basel on a suitable monitoring unit from 01.01.2014 - 28.02.2025. Exclusion Criteria: * Patients younger than 18 years * Patients who did not receive suitable EEG monitoring * Patients with documented refusal of the general consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neurologic dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Neurologic Manifestations

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurologic dysfunction

Contacts and locations

Locations

  • University Hospital Basel, Clinic for Intensive Care Medicine

    Basel, Canton of Basel-City, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.